Advertisement
Advertisement
ACH
Accendra Health, Inc.
2.80
USDSponsored
-0.12
-4.11%
Aug 07, 15:59 UTC -4
Closed
After-Market
2.81
+0.01
+0.36%
ACH Earnings Reports
Positive Surprise Ratio
ACH beat 2 of 3 last estimates.
67%
Next Report
Tomorrow BMO
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$633.58M
/-$0.08
Implied change from Q1 26 (Revenue/ EPS)
+0.92%
/+100.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/-130.77%
Accendra Health, Inc. earnings per share and revenue
On May 11, 2026, ACH reported earnings of -0.04 USD per share (EPS) for Q1 26, beating the estimate of -0.10 USD, resulting in a 60.90% surprise. Revenue reached 627.78 million, compared to an expected 651.08 million, with a -3.58% difference. The market reacted with a +0.81% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.08 USD, with revenue projected to reach 633.58 million USD, implying an increase of 100.00% EPS, and increase of 0.92% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
FAQ
What were Accendra Health, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Accendra Health, Inc. reported EPS of -$0.04, beating estimates by 60.9%, and revenue of $627.78M, -3.58% below expectations.
How did the market react to Accendra Health, Inc.'s Q1 2026 earnings?
The stock price moved up 0.81%, changed from $3.71 before the earnings release to $3.74 the day after.
When is Accendra Health, Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Accendra Health, Inc.'s next earnings report?
Based on --
analysts, Accendra Health, Inc. is expected to report EPS of -$0.08 and revenue of $633.58M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement